Report Detail

Request for Sample of this report

Service & Software Global Computer-assisted Drug Design Platform Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4680111
    • |
  • 26 February, 2026
    • |
  • Global
    • |
  • 114 Pages
    • |
  • GIR
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global Computer-assisted Drug Design Platform market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Computer-assisted Drug Design Platform market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Computer-assisted Drug Design Platform market size and forecasts, in consumption value ($ Million), 2021-2032
Global Computer-assisted Drug Design Platform market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Computer-assisted Drug Design Platform market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Computer-assisted Drug Design Platform market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Computer-assisted Drug Design Platform
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Computer-assisted Drug Design Platform market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Entelos, Crown Bioscience, Chemical Computing Group, Nimbus Therapeutics, Schrodinger, Dassault Systemes, Genedata, Biognos, Leadscope, Rhenovia Pharma Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Computer-assisted Drug Design Platform market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cloud-based
On-premise
Market segment by Application
Drug Discovery and Development
Computational Physiological Medicine
Disease Modeling
Medical Imaging
Predictive Analysis of Drug Targets
Market segment by players, this report covers
Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Certara LP
Prosarix
Simulations Plus
Strand Life Sciences
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Computer-assisted Drug Design Platform product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Computer-assisted Drug Design Platform, with revenue, gross margin, and global market share of Computer-assisted Drug Design Platform from 2021 to 2026.
Chapter 3, the Computer-assisted Drug Design Platform competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Computer-assisted Drug Design Platform market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Computer-assisted Drug Design Platform.
Chapter 13, to describe Computer-assisted Drug Design Platform research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Computer-assisted Drug Design Platform by Type
    • 1.3.1 Overview: Global Computer-assisted Drug Design Platform Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Computer-assisted Drug Design Platform Consumption Value Market Share by Type in 2025
    • 1.3.3 Cloud-based
    • 1.3.4 On-premise
  • 1.4 Global Computer-assisted Drug Design Platform Market by Application
    • 1.4.1 Overview: Global Computer-assisted Drug Design Platform Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Drug Discovery and Development
    • 1.4.3 Computational Physiological Medicine
    • 1.4.4 Disease Modeling
    • 1.4.5 Medical Imaging
    • 1.4.6 Predictive Analysis of Drug Targets
  • 1.5 Global Computer-assisted Drug Design Platform Market Size & Forecast
  • 1.6 Global Computer-assisted Drug Design Platform Market Size and Forecast by Region
    • 1.6.1 Global Computer-assisted Drug Design Platform Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Computer-assisted Drug Design Platform Market Size by Region, (2021-2032)
    • 1.6.3 North America Computer-assisted Drug Design Platform Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Computer-assisted Drug Design Platform Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Computer-assisted Drug Design Platform Market Size and Prospect (2021-2032)
    • 1.6.6 South America Computer-assisted Drug Design Platform Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Computer-assisted Drug Design Platform Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Entelos
    • 2.1.1 Entelos Details
    • 2.1.2 Entelos Major Business
    • 2.1.3 Entelos Computer-assisted Drug Design Platform Product and Solutions
    • 2.1.4 Entelos Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Entelos Recent Developments and Future Plans
  • 2.2 Crown Bioscience
    • 2.2.1 Crown Bioscience Details
    • 2.2.2 Crown Bioscience Major Business
    • 2.2.3 Crown Bioscience Computer-assisted Drug Design Platform Product and Solutions
    • 2.2.4 Crown Bioscience Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Crown Bioscience Recent Developments and Future Plans
  • 2.3 Chemical Computing Group
    • 2.3.1 Chemical Computing Group Details
    • 2.3.2 Chemical Computing Group Major Business
    • 2.3.3 Chemical Computing Group Computer-assisted Drug Design Platform Product and Solutions
    • 2.3.4 Chemical Computing Group Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Chemical Computing Group Recent Developments and Future Plans
  • 2.4 Nimbus Therapeutics
    • 2.4.1 Nimbus Therapeutics Details
    • 2.4.2 Nimbus Therapeutics Major Business
    • 2.4.3 Nimbus Therapeutics Computer-assisted Drug Design Platform Product and Solutions
    • 2.4.4 Nimbus Therapeutics Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Nimbus Therapeutics Recent Developments and Future Plans
  • 2.5 Schrodinger
    • 2.5.1 Schrodinger Details
    • 2.5.2 Schrodinger Major Business
    • 2.5.3 Schrodinger Computer-assisted Drug Design Platform Product and Solutions
    • 2.5.4 Schrodinger Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Schrodinger Recent Developments and Future Plans
  • 2.6 Dassault Systemes
    • 2.6.1 Dassault Systemes Details
    • 2.6.2 Dassault Systemes Major Business
    • 2.6.3 Dassault Systemes Computer-assisted Drug Design Platform Product and Solutions
    • 2.6.4 Dassault Systemes Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Dassault Systemes Recent Developments and Future Plans
  • 2.7 Genedata
    • 2.7.1 Genedata Details
    • 2.7.2 Genedata Major Business
    • 2.7.3 Genedata Computer-assisted Drug Design Platform Product and Solutions
    • 2.7.4 Genedata Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Genedata Recent Developments and Future Plans
  • 2.8 Biognos
    • 2.8.1 Biognos Details
    • 2.8.2 Biognos Major Business
    • 2.8.3 Biognos Computer-assisted Drug Design Platform Product and Solutions
    • 2.8.4 Biognos Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Biognos Recent Developments and Future Plans
  • 2.9 Leadscope
    • 2.9.1 Leadscope Details
    • 2.9.2 Leadscope Major Business
    • 2.9.3 Leadscope Computer-assisted Drug Design Platform Product and Solutions
    • 2.9.4 Leadscope Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Leadscope Recent Developments and Future Plans
  • 2.10 Rhenovia Pharma Limited
    • 2.10.1 Rhenovia Pharma Limited Details
    • 2.10.2 Rhenovia Pharma Limited Major Business
    • 2.10.3 Rhenovia Pharma Limited Computer-assisted Drug Design Platform Product and Solutions
    • 2.10.4 Rhenovia Pharma Limited Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Rhenovia Pharma Limited Recent Developments and Future Plans
  • 2.11 Compugen
    • 2.11.1 Compugen Details
    • 2.11.2 Compugen Major Business
    • 2.11.3 Compugen Computer-assisted Drug Design Platform Product and Solutions
    • 2.11.4 Compugen Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Compugen Recent Developments and Future Plans
  • 2.12 Certara LP
    • 2.12.1 Certara LP Details
    • 2.12.2 Certara LP Major Business
    • 2.12.3 Certara LP Computer-assisted Drug Design Platform Product and Solutions
    • 2.12.4 Certara LP Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Certara LP Recent Developments and Future Plans
  • 2.13 Prosarix
    • 2.13.1 Prosarix Details
    • 2.13.2 Prosarix Major Business
    • 2.13.3 Prosarix Computer-assisted Drug Design Platform Product and Solutions
    • 2.13.4 Prosarix Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Prosarix Recent Developments and Future Plans
  • 2.14 Simulations Plus
    • 2.14.1 Simulations Plus Details
    • 2.14.2 Simulations Plus Major Business
    • 2.14.3 Simulations Plus Computer-assisted Drug Design Platform Product and Solutions
    • 2.14.4 Simulations Plus Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Simulations Plus Recent Developments and Future Plans
  • 2.15 Strand Life Sciences
    • 2.15.1 Strand Life Sciences Details
    • 2.15.2 Strand Life Sciences Major Business
    • 2.15.3 Strand Life Sciences Computer-assisted Drug Design Platform Product and Solutions
    • 2.15.4 Strand Life Sciences Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Strand Life Sciences Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Computer-assisted Drug Design Platform Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Computer-assisted Drug Design Platform by Company Revenue
    • 3.2.2 Top 3 Computer-assisted Drug Design Platform Players Market Share in 2025
    • 3.2.3 Top 6 Computer-assisted Drug Design Platform Players Market Share in 2025
  • 3.3 Computer-assisted Drug Design Platform Market: Overall Company Footprint Analysis
    • 3.3.1 Computer-assisted Drug Design Platform Market: Region Footprint
    • 3.3.2 Computer-assisted Drug Design Platform Market: Company Product Type Footprint
    • 3.3.3 Computer-assisted Drug Design Platform Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Computer-assisted Drug Design Platform Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Computer-assisted Drug Design Platform Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Computer-assisted Drug Design Platform Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Computer-assisted Drug Design Platform Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Computer-assisted Drug Design Platform Consumption Value by Type (2021-2032)
  • 6.2 North America Computer-assisted Drug Design Platform Market Size by Application (2021-2032)
  • 6.3 North America Computer-assisted Drug Design Platform Market Size by Country
    • 6.3.1 North America Computer-assisted Drug Design Platform Consumption Value by Country (2021-2032)
    • 6.3.2 United States Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Computer-assisted Drug Design Platform Consumption Value by Type (2021-2032)
  • 7.2 Europe Computer-assisted Drug Design Platform Consumption Value by Application (2021-2032)
  • 7.3 Europe Computer-assisted Drug Design Platform Market Size by Country
    • 7.3.1 Europe Computer-assisted Drug Design Platform Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)
    • 7.3.3 France Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Computer-assisted Drug Design Platform Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Computer-assisted Drug Design Platform Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Computer-assisted Drug Design Platform Market Size by Region
    • 8.3.1 Asia-Pacific Computer-assisted Drug Design Platform Consumption Value by Region (2021-2032)
    • 8.3.2 China Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)
    • 8.3.5 India Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Computer-assisted Drug Design Platform Consumption Value by Type (2021-2032)
  • 9.2 South America Computer-assisted Drug Design Platform Consumption Value by Application (2021-2032)
  • 9.3 South America Computer-assisted Drug Design Platform Market Size by Country
    • 9.3.1 South America Computer-assisted Drug Design Platform Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Computer-assisted Drug Design Platform Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Computer-assisted Drug Design Platform Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Computer-assisted Drug Design Platform Market Size by Country
    • 10.3.1 Middle East & Africa Computer-assisted Drug Design Platform Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Computer-assisted Drug Design Platform Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Computer-assisted Drug Design Platform Market Drivers
  • 11.2 Computer-assisted Drug Design Platform Market Restraints
  • 11.3 Computer-assisted Drug Design Platform Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Computer-assisted Drug Design Platform Industry Chain
  • 12.2 Computer-assisted Drug Design Platform Upstream Analysis
  • 12.3 Computer-assisted Drug Design Platform Midstream Analysis
  • 12.4 Computer-assisted Drug Design Platform Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Computer-assisted Drug Design Platform. Industry analysis & Market Report on Computer-assisted Drug Design Platform is a syndicated market report, published as Global Computer-assisted Drug Design Platform Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Computer-assisted Drug Design Platform market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo